National Pharmaceuticals Pricing Authority will implement the new policy and the Livemint.com, 3 days ago
India Moves Forward In Policy To Lower Cost Of Pharmaceuticals; Medicine Is Expected To Be 25% Cheaper, 80% Less For Cancer Drugs - International Business Times, 1 day ago
Drug pricing order hits few, helps many - Financial Express, 3 days ago
See all (41) images for "national pharmaceutical pricing authority"
The National Pharmaceutical Pricing Authority (NPPA) is still scouting for the partners to roll out the ambitious project of SMS-based helpline through which the consumers will be able to choose the cheapest brand of a drug prescribed by doctors.PharmaBiz, 4 days ago Dept of Consumer Affairs backs out from sharing costs of consumer awareness campaign by NPPA PharmaBiz, 6 days ago
Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has denied a price hike to Sanofi, Novartis, and Allergan for some of their imported products.Business Standard, 1 week ago Big pharma can't raise prices of imported drugs Smart Investor, 1 week ago NPPA hikes price of anti-malarial drug chloroquine, revises prices of 42 formulation packs PharmaBiz, 1 week ago Sanofi cant raise drug prices for superior packaging Economic Times, 1 month ago
The department of pharmaceuticals has asked the National Pharmaceutical Pricing Authority to review Eli Lilly’s imported insulin prices, kept in check in recent months.The move could result in prices of imported insulin rising, against the regulator’s attempt to pull these down. The department, in a recent order, asked NPPA to revisit prices fixed for Eli Lilly’s five imported insulin products and bring these at par with other imported products.It also asked the regulator to ...Rediff.com, 2 months ago Imported insulin to cost more as NPPA told to review prices Business Standard, 2 months ago
The National Pharmaceutical Pricing Authority has named a number of drug makers for allegedly overcharging consumers for many essential medicines, amounting to a total of Rs 2,362 crore (Rs 23.62 billion) over the past few years.Those named include prominent firms such as as Cipla, Dr Reddy’s Labs and Ranbaxy.According to the regulator, Cipla has overcharged consumers on several essential medicines such as formulations based on salbutamol, cloxacillin, ciprofloxacin and norfloxacin.Prices ...Rediff.com, 2 months ago Price regulator alleges overcharging of Rs 2,362 cr by major drug makers Business Standard, 2 months ago
Related to : Dr Reddys Laboratories Ltd Dr Reddys Laboratories Ltd BSE 17 May 13 | 12:00 AM 2077.65 -38 (-1.8%) NSE 17 May 13 | 12:00 AM 2078.30 -40.65 (-1.92%) Hyderabad-based pharmaceutical major Dr Reddy's Laboratories Limited has welcomed ...Smart Investor, 2 days ago
Pharmaceutical companies should be allowed to continue to fix their own prices for individual drugs, according to a new report from 2020health. The independent health think tank report "Value-based pricing: the wrong medicine for the nation?" ...PJ Online, 1 week ago Value-Based Pricing Could Impact Access to Treatments EyeForPharma.com, 1 week ago
Research and Markets (http://www.researchandmarkets.com/research/pr4lpw/the_worldwide) has announced the addition of the "" report to their offering. Provides insight into pharmaceutical pricing and reimbursement systems around the world! The issues ...Individual.com, 1 week ago Research and Markets: The Worldwide Guide to Pricing & Reimbursement TMC Net, 1 week ago World Pricing & Reimbursement Reviewed by Espicom in New Report Now Available at MarketPublishers.com OSIX News, 3 weeks ago
More from: , Research and Markets...and 5 other sources
Both authoritarian and democratic governments are growing more distant from their angry citizens Banking on the 'purdah' principle Kanika Datta The more we segregate the genders, the worse things will get for women Negotiating China's future T S Vishwanath ...Business Standard, 1 month ago Insulin-prices-likely-to-increase-sharply Hindustan Times, 1 month ago
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or the "Company") (NASDAQ: AVEO).(Logo: ...Sys-Con India, 2 days ago
on your WebpageAdd Widget >Get your members hooked!